First National Bank of Mount Dora Trust Investment Services Has $3.20 Million Position in CVS Health Corp (CVS)

First National Bank of Mount Dora Trust Investment Services decreased its stake in shares of CVS Health Corp (NYSE:CVS) by 6.9% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 39,390 shares of the pharmacy operator’s stock after selling 2,922 shares during the quarter. First National Bank of Mount Dora Trust Investment Services’ holdings in CVS Health were worth $3,204,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the stock. Fieldpoint Private Securities LLC increased its stake in CVS Health by 333.3% during the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,000 shares during the last quarter. MPS Loria Financial Planners LLC acquired a new stake in CVS Health during the second quarter worth $119,000. Gemmer Asset Management LLC increased its stake in CVS Health by 15.3% during the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after acquiring an additional 200 shares during the last quarter. Captrust Financial Advisors acquired a new stake in CVS Health during the second quarter worth $155,000. Finally, Grace & White Inc. NY acquired a new stake in CVS Health during the second quarter worth $199,000. Hedge funds and other institutional investors own 82.24% of the company’s stock.

CVS has been the subject of several recent analyst reports. Needham & Company LLC reissued a “hold” rating on shares of CVS Health in a research note on Sunday, September 10th. Oppenheimer reissued a “buy” rating and set a $95.00 target price on shares of CVS Health in a research note on Monday, October 9th. Leerink Swann reissued an “outperform” rating and set a $85.00 target price (down previously from $90.00) on shares of CVS Health in a research note on Tuesday, November 7th. BidaskClub cut CVS Health from a “hold” rating to a “sell” rating in a research note on Friday, August 25th. Finally, SunTrust Banks set a $85.00 target price on CVS Health and gave the stock a “buy” rating in a research note on Thursday, October 12th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $86.35.

Shares of CVS Health Corp (NYSE:CVS) opened at $73.08 on Friday. CVS Health Corp has a one year low of $66.45 and a one year high of $84.72. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $74,029.46, a price-to-earnings ratio of 12.80, a PEG ratio of 1.37 and a beta of 0.89.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.01. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The business had revenue of $46.18 billion during the quarter, compared to analysts’ expectations of $46.17 billion. During the same period in the previous year, the firm posted $1.64 earnings per share. The company’s revenue was up 3.5% on a year-over-year basis. sell-side analysts predict that CVS Health Corp will post 5.9 EPS for the current fiscal year.

In related news, EVP Thomas M. Moriarty sold 20,547 shares of the business’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the completion of the transaction, the executive vice president now directly owns 43,178 shares of the company’s stock, valued at approximately $3,504,758.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Jonathan C. Roberts sold 85,743 shares of the business’s stock in a transaction on Monday, September 18th. The stock was sold at an average price of $83.14, for a total value of $7,128,673.02. Following the transaction, the chief operating officer now directly owns 119,555 shares of the company’s stock, valued at $9,939,802.70. The disclosure for this sale can be found here. Insiders own 0.61% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://stocknewstimes.com/2017/12/17/first-national-bank-of-mount-dora-trust-investment-services-has-3-20-million-position-in-cvs-health-corp-cvs.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply